logo
Low Impact Exercise Options for Seniors

Low Impact Exercise Options for Seniors

Health Line23-05-2025
Older adults have many options for staying physically active without sacrificing their joints. Walking, cycling, and yoga are just a few low impact exercises that may offer benefits.
As you get older, your body changes. With it, your fitness needs change.
Certain activities, like running, can place stress on your musculoskeletal system. For many people, this may mean those activities are no longer comfortable, enjoyable, or, in some cases, safe.
But getting older doesn't mean you need to stop moving. Low impact exercises can enhance strength, promote flexibility, and build cardiovascular fitness without placing excessive stress on your joints.
Plus, physical activity offers various mental health benefits.
In this article, we discuss some options for low impact exercises, along with considerations for picking the right activity for you and staying safe while doing it.
Exercise considerations for older adults
Every person will have different exercise needs. Factors such as fitness level, age, and health status can all play a role in determining what the most suitable form of exercise is for an individual.
The goal should be to find an exercise that you enjoy, gets you moving, doesn't stress your joints, and is convenient for you.
If you have any questions, you can speak with a healthcare professional for advice. You might also consider working with a trainer who has experience with older adults, if you have access to one.
Low impact exercises
Most of these options for low impact exercise offer great flexibility. They don't require much specialized equipment, and you can perform many of them in your home.
Walking
Walking has many potential health and antiaging benefits. According to a 2023 research review, these include improvements in areas such as:
cardiovascular health
mental well-being
sleep
cognition
all-cause mortality
If you're trying to decide how much to walk, the Centers for Disease Control and Prevention (CDC) guidelines on activity can be a good starting point. The CDC suggests getting at least 150 minutes of moderate-intensity activity each week.
For walking, this could mean doing 30 minutes of brisk walking 5 days per week.
Alternately, the authors of the research review suggest aiming for 6,000 to 8,000 steps per day.
Chair exercises
Chair exercises are simple, convenient fitness routines that involve using a chair to perform exercises geared toward stretching, building strength, and enhancing mobility.
A 2021 study found that chair exercise programs can improve the functioning of your arms and legs.
Yoga
Yoga is a practice that combines physical movement with breathwork and meditation. It involves doing gentle stretching while holding poses that engage the core and other large muscle groups.
Many yoga poses can be modified for beginner practitioners or those with mobility challenges. If going through a traditional yoga routine feels daunting, chair yoga could be a good place to start.
Strength training
Strength training is great for building muscle. Many activities fall under the umbrella of strength training, including those involving weights, elastic resistance bands, and even your body weight.
Research from 2019 suggests that strength training can help older adults stay independent and preserve their quality of life by:
counteracting muscle loss
reducing physical vulnerability
helping manage chronic conditions
building resilience
In fact, the CDC recommends that older adults do two strength training sessions per week.
Cycling
Cycling is a low impact activity that can get folks moving and exploring the outdoors. Today many manufacturers make comfortable, lightweight bicycles designed for older adults. And electric bikes (e-bikes) make riding easier than ever.
A 2023 review of cycling in older populations found that its benefits include better joint mobility, cardiovascular health, and mental well-being.
Tai chi
Tai chi is a traditional Chinese practice that combines flowing movements with mindfulness. It is a relaxing, low impact activity that offers a variety of potential benefits.
A 2021 review found that regular tai chi practice can improve areas such as:
balance
pain management
brain function
sleep
immune function
You may find group classes in community centers, parks, or gyms, or you can follow along at home with online videos.
SilverSneakers
Certain Medicare Advantage (Part C) plans offer fitness benefits through a program called SilverSneakers.
These benefits allow members to access gyms and exercise classes specifically designed for older adults. Classes are in-person or online and focus on maximizing fitness benefits while being low impact.
Classes include:
swimming
yoga
strength training
tai chi
dance
aerobics
fall prevention
Staying safe while exercising
As an older adult, staying healthy is key to a successful exercise program. Even with low impact exercises, there's a risk of burning out or developing overuse injuries.
Here are some quick tips to consider that can help you create and implement a sustainable exercise program:
Start slow: Allow your body time to adapt to any new stimulus by building up slowly and not overdoing it in the beginning.
Listen to your body: If you feel particularly fatigued or sore, it may be time for rest and recovery. If in doubt, speak with a healthcare professional for advice.
Speak with a trainer: Certain activities, like resistance training and yoga, require exact form to do them properly. A trainer or instructor can be a helpful resource, especially when you're learning a new exercise.
Fuel properly: Your muscles need energy for activity, so try to eat nutritious foods and stay hydrated during your workouts.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs
BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs

Yahoo

time17 minutes ago

  • Yahoo

BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs

FRANKLIN LAKES, N.J., July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas™ Wearable Injector for subcutaneous delivery of complex biologics. The selection of BD Libertas™ Wearable Injector for this pharma-sponsored trial follows successful outcomes from more than 50 BD-conducted pre-clinical and clinical studies, including a device clinical study demonstrating excellent performance with 100% of study participants stating they would likely use the BD Libertas™ Wearable Injector if prescribedi,ii. The pharma-sponsored combination product clinical trial represents a significant advancement in accelerating innovation in drug-device combination products that provide greater flexibility for patients, including potential conversion from infused medications that require patients to travel to a hospital or clinic to more convenient patient care in various settings, including self-injection at home. "This trial demonstrates BD's commitment to helping pharma companies by advancing large-volume injection science, ensuring therapies are accessible and patient friendly by offering more efficient and convenient options for biologics," said Patrick Jeukenne, worldwide president of BD Pharmaceutical Systems. "BD's enhanced testing capabilities acquired through ZebraSci and the proven capabilities of the BD Libertas™ Wearable Injector technology further position BD as an innovative leader in drug delivery." The BD Libertas™ Wearable Injector is an innovative, prefilled, patient ready-to-use drug delivery systemiii designed to enable delivery of complex biologics via subcutaneous injection. The biologics market is expected to grow to more than $670 billioniv by 2030 and for pharmaceutical companies developing these complex drugs, the BD Libertas™ Wearable Injector offers a customizable, patient-centric solution. The BD Libertas™ Wearable Injector: Supports delivery of high-viscosity biologics (up to 50 centipoise), enabling a wide range of subcutaneous therapies Is offered in 2 to 5 mL and 5 to 10 mL configurations providing flexibility for diverse therapeutic requirements Features a fully mechanical, patient ready-to-use design with a simple "peel, stick and click" mechanism, requiring no end-user filling or assemblyiii BD's ongoing validations of fill-finish and final assembly processes with multiple Contract Manufacturing Organizations (CMOs) enable the company to support pharmaceutical partners from development through commercial-scale production. For more information about how BD Libertas™ Wearable Injector is enabling biologic therapy delivery, visit About BD Libertas™ Wearable InjectorBD Libertas™ Wearable Injector is a product in development; some statements are forward looking and are subject to a variety of risks and uncertainties. BD Libertas™ Wearable Injector is a device component intended for drug-device combination products and not subject to FDA 510(k) clearance or separate EU CE mark certification. About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit or connect with us on LinkedIn at X (formerly Twitter) @BDandCo or Instagram @becton_dickinson. Contacts: Media: Investors: Fallon McLoughlin Adam Reiffe BD Corporate Communications BD Investor Relations 201.258.0361 201.847.6927 i Early feasibility clinical study of investigational BD Libertas™ Wearable Injector (WI) evaluated 5ml, non- Newtonian ~8cP subcutaneous placebo injections in 52 healthy adult subjects for functionality, tissue effects, subject tolerability (100mm Visual Analog Scale (VAS)) and acceptability (questionnaires with 5-point Likert or yes /no responses). Tissue effects were measured from WI removal post-injection through 24 hours with calipers (wheals) or graded on a 5-point scale (erythema, bleeding) from 0-none to 4-severe, significant, respectively. Where tissue effects were observed, the majority (>50%) were resolved within 60 minutes and all within 24 hours. Subject pain (100mm VAS) peaked mid-injection (mean 9.1mm, SD 13.4) and rapidly resolved within 30 minutes (mean 0 .4mm, SD 2.6). Subjects found acceptable (Likert agree + strongly agree or yes responses) their peak pain (≥90.2%), injection site appearance (≥92.2% ).ii Woodley, W. D. et al. Clinical Evaluation of an Investigational 5ml Wearable Injector in Healthy Human Subjects. Clin Transl Sci. 2021 May;14(3):859-869. Pharma filled and assemblediv Mordor Intelligence (2025). Biologics Market Size - Industry Report on Share, Growth Trends & Forecasts Analysis (2025 - 2030). View original content to download multimedia: SOURCE BD (Becton, Dickinson and Company) Sign in to access your portfolio

U.S. Physical Therapy, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call Dates
U.S. Physical Therapy, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call Dates

Yahoo

time17 minutes ago

  • Yahoo

U.S. Physical Therapy, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call Dates

HOUSTON, July 23, 2025--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the three months and six months ended June 30, 2025, on Wednesday, August 6, 2025, after the stock market closes, with the conference call to follow the next morning, on Thursday, August 7, 2025. Conference Call Date: Thursday, August 7, 2025 Time: 10:30 am Eastern / 9:30 am Central Dial-In Number: (800) 343-4136 Primary or (203) 518-9843 Alternate Conference ID: USPHQ225 (In order to join this conference call,you will be required to provide the Conference ID listed above) To participate, please call in 15 minutes prior to start time. To listen to the live call, please go to and click on conference calls under the Investor Relations section. Please go to the website 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, a playback of the conference call can be accessed until November 5, 2025 at USPH's website. About U.S. Physical Therapy, Inc. Founded in 1990, U.S. Physical Therapy, Inc. owns and/or manages 768 outpatient physical therapy clinics in 44 states. USPH clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured workers. USPH also has an industrial injury prevention business which provides onsite services for clients' employees including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments. More information about U.S. Physical Therapy, Inc. is available at The information included on that website is not incorporated into this press release. View source version on Contacts U.S. Physical Therapy, Hendrickson, Chief Financial OfficerEmail: Chendrickson@ Chris Reading, Chief Executive Officer(713) 297-7000 Three Part AdvisorsJoe Noyons(817) 778-8424

The president vows to slash medication cost to an unachievable degree.
The president vows to slash medication cost to an unachievable degree.

Yahoo

time17 minutes ago

  • Yahoo

The president vows to slash medication cost to an unachievable degree.

President Donald Trump has promised to reduce American drug prices by mathematically impossible figures of up to '1400 percent.' Speaking during a White House event attended by Republican members of Congress and his Cabinet, Trump said he would tackle the long-running issue of high medication costs in the U.S. But Trump did not set any achievable targets for that aim, instead outlining a range of percentages which would yield negative prices, meaning drug companies would have to pay people to take their medications.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store